A24 IPF: CLINICAL STUDIES, THERAPEUTICS, AND MORE I: Demographics And Healthcare Utilization Of Patients With Idiopathic Pulmonary Fibrosis (ipf) In A Real-World Setting: Updated Findings From 277 Patients In The Proof Registry

Rationale: IPF is an irreversible, unpredictable, and ultimately fatal lung disease characterized by a progressive loss of lung function. Conclusions: The PROOF registry provides valuable information on the characteristics of patients with IPF in a realworld setting, including insights into the high burdens of associated comorbidities and concomitant medications in this population, as well as hospitalization needs.